Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer

Ibrahim Tekedereli, S. Neslihan Alpay, Clint D.J. Tavares, Zehra E. Cobanoglu, Tamer S. Kaoud, Ibrahim Sahin, Anil K. Sood, Gabriel Lopez-Berestein, Kevin N. Dalby, Bulent Ozpolat

Research output: Contribution to journal › Article › peer-review

93 Scopus citations

Fingerprint

Dive into the research topics of 'Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences